Navigation Links
Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership
Date:1/15/2014

IPSWICH, England, January 15, 2014 /PRNewswire/ --

A study has been launched to test whether technology developed to win races on the Formula 1 track could help to tackle the problem of obesity.  This unique healthcare collaboration between McLaren Applied Technologies (MAT), Stowhealth (a GP surgery based in Stowmarket) and academics at University Campus Suffolk is being funded by healthcare provider Simplyhealth.

Telemetry technology, which is inspired by equipment used to collect data about the on-track performance of Vodafone McLaren Mercedes Formula 1 cars, has been developed to monitor the activity levels of obese individuals in an innovative year-long research study.

The Helping Health Change study, which highlights the role technology can play in supporting healthy futures, aims to educate individuals about the relationship between the energy in their food versus the energy that their body burns through physical activity. This is intended to help them make healthier lifestyle choices, thus preventing long-term health issues from developing.

This cutting-edge weight management programme, supported by insurer Simplyhealth, aims to recruit 90 patients within Stowhealth medical practice.  A sample of individuals will be given an MAT device that will monitor their physical movements and calories burnt. During the research programme participants will receive exercise advice and help with healthy eating habits. Their progress will be analysed by researchers at University Campus Suffolk.

The project is also intended to demonstrate that a partnership of diverse organisations with fresh perspectives on healthcare challenges can help to address significant issues, hopefully inspiring the formation of further innovative projects in future.

Simon Rudland, a GP at Stowhealth who championed the research project said: "Obesity is a problem that affects roughly a quarter of adults in the UK - and evidence suggests that these numbers are rising. Our hope is that Helping Health Change study funded by Simplyhealth will help shape the way we empower the vast number of individuals with weight-related conditions to make informed decisions based on accurate, factual evidence. The long-term aim is for this programme to inform the healthcare industry and demonstrate what can be achieved by bringing together diverse groups with different expertise and perspectives to address significant health issues."

Geoff McGrath, Managing Director of McLaren Applied Technologies said: "How we manage the health and performance of a racing car, week in week out, and what doctors are looking to achieve in the monitoring of patients, is not that different.

"We develop systems that collect, transmit and manage vast amounts of data per race to better understand how the car is performing and diagnose any changes that need to be made. We are applying the same approach to this study, but in this instance to help provide an accurate and well-informed picture of an individual's energy usage. The key thing here is making the collected data useful and interpretable for GPs, so that they can provide tailored advice to their patients.

"Though this joint research project is relatively small-scale at present, it demonstrates how health groups and technology companies can work together to tackle health problems in the future, and we hope that this is the first of many such collaborations."

Professor Brendon Noble, Head of School of Science, Technology and Health at University Campus Suffolk said:  "These are the first steps in a revolution in healthcare technologies and we are delighted that our experts are helping to drive this forward. Here in Suffolk we are contributing to the NHS's aim that innovation is at the core of the healthcare offer to patients."  

Romana Abdin, Simplyhealth's CEO said:  "We're very pleased to have played a role in helping bring together this unique partnership and opportunity to the fore. As obesity continues to pose as a barrier to good health and the future health of many individuals in the UK, now is absolutely the right time to explore how technology can support weight loss. At Simplyhealth we want to inspire people to better health and this project seeks to do that by explaining the relationship between food and physical activity through facts and not just estimates. We look forward to seeing the outcomes of the pilot and how it informs research in this area."

Notes to editors

About Simplyhealth:

  1. Simplyhealth has been providing healthcare solutions for over 140 years, dedicated to serving its customers and patients through a variety of cash plans, dental plans, private medical insurance, self funded health plans and mobility and living aids
  2. Simplyhealth as it stands today, now covers nearly four million people with health plans (more than any other company) and helps 20,000 companies with their employees' health
  3. Simplyhealth is committed to making a positive impact on its communities. Each year, we donate over £1 million to health related charities and causes
  4. Simplyhealth is a trading name of Simplyhealth Access, which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority
  5. For more information about Simplyhealth, please visit http://www.simplyhealth.co.uk

About McLaren Applied Technologies:

  1. McLaren Applied Technologies is one of the McLaren Group's most diverse and fast-moving businesses. With expertise in high performance design, performance management systems and simulation systems, MAT works in strategic partnerships with visionaries and market leaders in four core industry areas: energy, health & wellness, sport and automotive.

About Stowhealth:

  1. Stowhealth is a leading and award winning innovative GP practice in the heart of Suffolk. It has a philosophy of delivery holistic integrated healthcare, promoting and delivering a wide range of NHS and Complimentary health services to its 17,500 patients.
  2. Stowhealth is committed to people having active healthy lifestyles and wants to help innovate the way individuals lose weight and support them in making healthy choices.

About University Campus Suffolk (UCS):

  1. UCS is a partnership between the University of East Anglia and the University of Essex, working with Lowestoft College, Great Yarmouth College, Otley College, Suffolk New College and West Suffolk College. The development is also supported by Suffolk County Council and Ipswich Borough Council.
  2. UCS offers an attractive portfolio of courses within the Schools of Applied Social Science, Arts and Humanities, Nursing and Midwifery, Business, Leadership and Enterprise, and Science, Technology and Health at Undergraduate and Postgraduate level. This is complemented by a range of research in these areas.

For more information contact:
Simon Smith
UCS Communications Officer
+44(0)1473-338008 / +44(0)7872421098
simon.smith.1@ucs.ac.uk


'/>"/>
SOURCE University Campus Suffolk (UCS)
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. New Biologics Must Show Improvements in Efficacy, Safety and Cost-Benefit Compared with Currently Available Agents for Inclusion on Formularies in Argentina, Brazil and Mexico
2. Success For Total: Historical Partner Of Formula 1 World Champions
3. Bend Research to Highlight Latest Drug Formulation Technologies
4. CA BOTANA International New Peptide Formulations
5. KBI Biopharma Selects Freeslate’s Biologics Formulation System for Early and Late Stage Drug Development
6. Freeslate’s Biologics Formulation System Selected by Sanofi Pasteur to Improve Efficiency of Formulation Development
7. Atomic Learning Takes Education on the Road with Formulate Fabric Displays from GLM Displays
8. Live Xtalks Webinar Highlights Vaccine and Biotherapeutic Formulation Development and Manufacture Using Spray-Drying
9. Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies
10. Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017
11. North America Injectable Drug Delivery Market - by Formulations, Devices & Therapeutics- Forecasts to 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... -- IsoRay, Inc. (NYSE MKT: ISR), a medical technology company ... for the treatment of prostate, brain, lung, head and ... for the second quarter and six months of fiscal ... --> --> Revenue was $1.19 ... ended December 31, 2015, a 12% increase compared to ...
(Date:2/10/2016)... Springfield, MO (PRWEB) , ... February 10, 2016 ... ... company, will attend the International Society of Pharmaceutical Engineering (ISPE) Rocky Mountain Chapter ... of ISPE is expecting to fill more than 100 tables for its annual ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... available on Microsoft Azure. On Azure, Arvados provides capabilities for managing and processing ... demand for Microsoft Azure from major institutions collecting and analyzing genomic data,” said ...
(Date:2/9/2016)... ... ... With a presidential election in November and the future of U.S. healthcare in ... top healthcare leaders for a night and day of debates and discussions about what ... the University of Pennsylvania’s Wharton School, will be held February 18 – 19, 2016 ...
Breaking Biology Technology:
(Date:2/2/2016)... Feb. 2, 2016 This BCC Research ... market by reviewing the recent advances in high ... drive the field forward. Includes forecast through 2019. ... the challenges and opportunities that exist in the ... solution developers, as well as IT and bioinformatics ...
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 Technology ... service presents an analysis of the digital and computed ... Malaysia , and Indonesia ... current trends and market size, as well as regional ... by country and discusses market penetration and market attractiveness, ...
(Date:2/2/2016)... , Feb. 2, 2016  Based on its ... & Sullivan recognizes US-based Intelligent Retinal Imaging Systems ... Sullivan Award for New Product Innovation. IRIS, a ... North America , is poised to ... growing diabetic retinopathy market. The IRIS technology presents ...
Breaking Biology News(10 mins):